Mount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease

New Approach Will Lead to a Better Understanding of Most Cases

Read more

Mount Sinai Researcher’s Examine the Metabolic Effects of an Oral Blood Cancer Drug

Recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure

Read more

Teaching Preschool Caregivers about Healthy Behaviors May Promote Healthier Lifestyle in Some High-Risk Groups

Study Shows Vascular Ultrasounds and Adhering to Interventional Education in Underserved Communities can Improve Health among Parents and School Staff

Read more

Mount Sinai Researchers Develop Novel Method to Identify Patterns Among Patients With Multiple Chronic Conditions

A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).

Read more

Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug

The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

Read more

Icahn School of Medicine at Mount Sinai Launches First-Of-Its-Kind Diversity Innovation Hub to Use Technology to Close Gaps in Local Health Care

The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai’s Office of Diversity and Inclusion.

Read more

Mount Sinai Researchers Bring Us One Step Closer to Universal Influenza Vaccine

A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).

Read more

Artificial Pancreas System Better Controls Blood Glucose Levels than Current Technology

Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes

Read more